For each participant in Part A of the CRYPTOFAZ study, the results from all DNA-based assays are displayed, including the plate-based 
enteroaggregative
CARD
CFZ, participant randomized to the clofazimine arm of the study; PCB, participant randomized to the placebo arm of the study; TAC, TaqMan Array Card; EAEC, enteroaggregative Baseline samples for our participants were analyzed to determine their 